Weiss Asset Management LP → Theravance Biopharma, Inc. TBPH

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

5 filings by this filer

4 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 7.84

5,262,895 shares short · +2.2% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $196K

Point72 Asset Mgmt

Other 13D/G Filings on Theravance Biopharma, Inc.

Filed	Form	Filer	Stake	Shares
2022-09-20	SC	GSK PLC	—	—	view →
2022-02-10	SC	GLAXOSMITHKLINE PLC	—	—	view →
2020-06-22	SC	GLAXOSMITHKLINE PLC	—	—	view →
2020-02-27	SC	GLAXOSMITHKLINE PLC	—	—	view →
2019-04-18	SC	GLAXOSMITHKLINE PLC	—	—	view →

Other Filings by Weiss Asset Management LP

Filed	Form	Issuer	Stake	Shares
2021-05-26	SC	CAI International, Inc.	—	—	view →
2021-04-30	SC	CAI International, Inc.	—	—	view →
2020-02-03	SC	CAI International, Inc.	—	—	view →
2019-11-22	SC	CAI International, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →